Connection
David Arciniegas to Central Nervous System Stimulants
This is a "connection" page, showing publications David Arciniegas has written about Central Nervous System Stimulants.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.282 |
|
|
|
-
McDonald BC, Flashman LA, Arciniegas DB, Ferguson RJ, Xing L, Harezlak J, Sprehn GC, Hammond FM, Maerlender AC, Kruck CL, Gillock KL, Frey K, Wall RN, Saykin AJ, McAllister TW. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial. Neuropsychopharmacology. 2017 Aug; 42(9):1766-1775.
Score: 0.118
-
Silver JM, McAllister TW, Arciniegas DB. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry. 2009 Jun; 166(6):653-61.
Score: 0.070
-
Arciniegas DB, Silver JM. Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol. 2006; 17(1):25-42.
Score: 0.055
-
Bridgeford D, Arciniegas DB, Batkis M, Sandberg E, Beresford TP. Methylphenidate treatment of neuropsychiatric symptoms of central and extrapontine myelinolysis. J Stud Alcohol. 2000 Sep; 61(5):657-60.
Score: 0.038